YOLFTbeta
BM

Bundamedik Tbk PT

BMHS · JK · Healthcare / Medical Care Facilities

188.00IDR+1.00 (+0.53%)

Price History

Full chart

Market Stats

Previous Close187.00
Open186.00
Day Range181.00 – 188.00
52-Week Range142.17 – 244.58
Volume802.90K
Market Cap1.72T
P/E (TTM)0.00
Forward P/E65.36
EPS-0.20
Dividend Yield0.52%
Beta-0.21
50-Day Avg193.40
200-Day Avg188.71

About

PT Bundamedik Tbk provides health care services in Indonesia. It also engages private hospital and healthcare support service activities; provision of ambulance services; private health education; consultant for reproductive technology services management; management consultant of physiotherapy service; and hotel, and dental clinic services management consulting businesses. It also provides fertility clinic, and oncology; emergency services; laboratory, radiology, and IVF services; and genomics and clinical pathology laboratory, and corporate health services. In addition, the company operates a BMHS nurse center, bunda neuro centre, bunda heart centre, bunda urology centre, digital substraction angiography, RSM oncology, and advanced robotic minimal invasive surgery. PT Bundamedik Tbk was founded in 1961 and is based in Jakarta Pusat, Indonesia. PT Bundamedik Tbk is a subsidiary of PT Bunda Investama Indonesia.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOMr. Agus Heru Darjono
  • Employees1.79K
  • HeadquartersJl. Teuku Cik Ditiro No.28, Jakarta Pusat, Indonesia, 10350, Indonesia
  • Websitehttps://www.bmhs.co.id

Leadership

  • Mr. Agus Heru DarjonoPresident Director
  • Ms. Emilia Rouli SimatupangDirector of Human Capital & Director · b. 1972
  • Mr. Tubagus Adi Satria PrakasaHead of Internal Audit & Risk Management Unit · b. 1985
  • Ms. Josephine PM TobingCorporate Secretary · b. 1982

Financials

Income Statement

Currency: IDR2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue852.23B964.89B1.15T1.71T1.66T1.49T1.55T1.61T
Growth (%)-+13.22%+18.99%+49.00%-3.04%-10.28%+4.47%+3.84%
Cost of Revenue454.39B507.77B654.99B887.24B894.14B905.94B847.55B991.25B
Gross Profit397.84B457.12B493.15B823.52B764.55B582.26B707.14B623.09B
Gross Margin46.68%47.38%42.95%48.14%46.09%39.13%45.48%38.60%
Operating Expense320.13B355.51B304.47B407.33B547.72B494.55B619.18B507.80B
Operating Income77.71B101.61B188.68B416.19B216.83B87.71B87.95B115.29B
Operating Margin9.12%10.53%16.43%24.33%13.07%5.89%5.66%7.14%
EBITDA122.53B155.81B265.85B570.28B344.13B203.45B212.48B239.90B
EBITDA Margin14.38%16.15%23.15%33.33%20.75%13.67%13.67%14.86%
Net Income5.13B31.32B118.46B315.36B128.93B7.46B11.94B12.42B
Net Income Margin0.60%3.25%10.32%18.43%7.77%0.50%0.77%0.77%
Interest Expense56.84B58.39B53.12B28.02B47.12B57.76B68.05B67.53B
Interest Expense % of Total Revenue6.67%6.05%4.63%1.64%2.84%3.88%4.38%4.18%

Balance Sheet

Currency: IDR2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.24T1.40T2.16T2.69T2.94T3.08T3.45T4.02T
Total Liabilities708.92B735.16B1.11T1.00T1.13T1.28T1.30T1.62T
Total Equity494.78B618.58B995.24B1.56T1.60T1.59T1.71T1.95T
Cash98.88B90.66B619.38B782.27B590.56B622.06B295.86B826.58B
Total Debt533.66B518.10B812.15B669.68B931.42B1.12T1.16T1.36T
Net Debt434.78B427.44B192.77B-116.06B340.86B497.90B868.07B529.20B

Cash Flow

Currency: IDR2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow43.79B89.72B190.36B349.44B237.47B51.44B33.98B250.62B
Investing Cash Flow-161.93B-76.29B-49.17B-249.57B-438.03B-212.22B-245.29B-217.01B
Financing Cash Flow53.84B-15.80B383.55B158.47B106.47B153.56B372.59B9.64B
Capital Expenditure156.54B72.50B49.61B228.08B301.73B209.35B236.03B218.91B
Free Cash Flow-112.75B17.21B140.75B121.36B-64.26B-157.91B-202.05B31.72B
Dividends Paid16.35B14.64B10.54B40.85B140.28B22.79B63.93B16.40B
FCF to OCF-257.48%19.19%73.94%34.73%-27.06%-307.00%-594.61%12.66%
Dividend Paid to FCF-14.50%85.06%7.49%33.66%-218.30%-14.43%-31.64%51.72%

Earnings

Report DateSep 30, 2021Dec 31, 2021May 24, 2022Aug 22, 2022Nov 22, 2022Dec 31, 2022May 2, 2023Jul 31, 2023
EPS Estimate--------
EPS Actual6.662.703.002.882.361.101.10-0.66
Surprise--------
Timing--After-hoursAfter-hoursAfter-hours-After-hoursAfter-hours

Key Statistics & Ratios

Market Cap1.72T
Enterprise Value2.98T
Trailing P/E0.00
Forward P/E65.36
Price / Sales1.06
Price / Book0.89
EPS-0.20
Book Value225.75
Revenue (TTM)1.62T
Gross Profit (TTM)734.22B
EBITDA164.86B
Profit Margin-0.07%
Operating Margin4.35%
Return on Equity0.09%
Return on Assets1.47%
Shares Outstanding8.60B
Shares Float2.05B
Beta-0.21
Dividend Yield0.52%
Dividend Rate1.03
Payout Ratio63.11%

Dividends

20261×
1.03Jun 23, 2026
20251×
0.65May 26, 2025
20241×
0.56Jun 10, 2024
20231×
1.50Jul 3, 2023
20221×
2.56Aug 1, 2022